283 related articles for article (PubMed ID: 32754191)
1. Gene Signature and Identification of Clinical Trait-Related m
Hou J; Wang Z; Li H; Zhang H; Luo L
Front Genet; 2020; 11():522. PubMed ID: 32754191
[TBL] [Abstract][Full Text] [Related]
2. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
3. m
Zhai J; Li S; Sen S; Opoku-Anane J; Du Y; Chen ZJ; Giudice LC
Front Genet; 2020; 11():716. PubMed ID: 32719721
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases.
Zhang X; Zhong L; Zou Z; Liang G; Tang Z; Li K; Tan S; Huang Y; Zhu X
Front Oncol; 2021; 11():623170. PubMed ID: 33816257
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP2-related modification patterns in pancreatic cancer: A machine learning-driven approach towards personalized treatment.
Chen D; Zang L; Zhou Y; Yang Y; Zhang X; Li Z; Shu Y; Gao W; Zhu H; Yu X
Heliyon; 2024 Mar; 10(6):e28243. PubMed ID: 38545193
[TBL] [Abstract][Full Text] [Related]
6. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma.
Tang R; Zhang Y; Liang C; Xu J; Meng Q; Hua J; Liu J; Zhang B; Yu X; Shi S
PeerJ; 2020; 8():e9602. PubMed ID: 33062408
[TBL] [Abstract][Full Text] [Related]
7. Identification of pathology-specific regulators of m
Li N; Zhan X
EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
Pan J; Xu L; Pan H
Front Oncol; 2020; 10():1444. PubMed ID: 32974164
[No Abstract] [Full Text] [Related]
9. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
11. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.
Xu F; Zhang Z; Yuan M; Zhao Y; Zhou Y; Pei H; Bai L
Cancer Invest; 2021 Jan; 39(1):39-54. PubMed ID: 33176521
[TBL] [Abstract][Full Text] [Related]
12. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
Front Genet; 2020; 11():994. PubMed ID: 33193582
[TBL] [Abstract][Full Text] [Related]
13. m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.
Hao L; Wang JM; Liu BQ; Yan J; Li C; Jiang JY; Zhao FY; Qiao HY; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118878. PubMed ID: 33011193
[TBL] [Abstract][Full Text] [Related]
14. A newly defined risk signature, consisting of three m
Fan L; Lin Y; Lei H; Shu G; He L; Yan Z; Rihan H; Yin G
Aging (Albany NY); 2020 Sep; 12(18):18453-18475. PubMed ID: 32950970
[TBL] [Abstract][Full Text] [Related]
15. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
16. The m6A readers
Anita R; Paramasivam A; Priyadharsini JV; Chitra S
Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
[TBL] [Abstract][Full Text] [Related]
17. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
Han X; Liu J; Cheng G; Cui S
Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
[TBL] [Abstract][Full Text] [Related]
18. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
19. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
Front Oncol; 2020; 10():536875. PubMed ID: 33134160
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and immunological characterization of RNA m
Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]